Stockholm3 Versus Prostate-specific Antigen in Prostate Cancer Screening: 9-year Outcomes Demonstrating Improved Detection of Aggressive Cancers and Reduced Overdiagnosis from the STHLM3 Trial

  • Hari T. Vigneswaran
  • , Thorgerdur Palsdottir
  • , Chiara Micoli
  • , Derya Tilki
  • , Daniel Lin
  • , Matthew Cooperberg
  • , Scott Eggener
  • , Ugo Giovanni Falagario
  • , Axel Möller
  • , Markus Aly
  • , Olof Akre
  • , Peter Wiklund
  • , Lars Egevad
  • , Henrik Grönberg
  • , Tobias Nordström
  • , Martin Eklund

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Stockholm3 Versus Prostate-specific Antigen in Prostate Cancer Screening: 9-year Outcomes Demonstrating Improved Detection of Aggressive Cancers and Reduced Overdiagnosis from the STHLM3 Trial'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry